BMS Keeps Focus On Growth, Continues Trump Administration Negotiations

Investors Watching For Late 2025 Cobenfy Readout

 
• By Mandy Jackson
  
Medicare drug price negotiations under the IRA for Pomalyst in 2027 are also under way (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Scrip

More from Earnings